
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6548432
[patent_doc_number] => 20100222381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/660477
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13218
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12660477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660477 | Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors | Feb 25, 2010 | Abandoned |
Array
(
[id] => 6432195
[patent_doc_number] => 20100143468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Tranexamic Acid Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/714181
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32289
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143468.pdf
[firstpage_image] =>[orig_patent_app_number] => 12714181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714181 | Tranexamic acid formulations | Feb 25, 2010 | Issued |
Array
(
[id] => 6502596
[patent_doc_number] => 20100260674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/694249
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11310
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694249
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694249 | QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT | Jan 25, 2010 | Abandoned |
Array
(
[id] => 6548879
[patent_doc_number] => 20100222406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'T Type Calcium Channel Blockers and the Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/687641
[patent_app_country] => US
[patent_app_date] => 2010-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7157
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12687641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687641 | T Type Calcium Channel Blockers and the Treatment of Diseases | Jan 13, 2010 | Abandoned |
Array
(
[id] => 7712205
[patent_doc_number] => 20120004327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'WATER-INSOLUBLE REACTION PRODUCT OF A POLYAMINE AND AN OIL-SOLUBLE HIGH CARBON POLAR MODIFIED POLYMER'
[patent_app_type] => utility
[patent_app_number] => 13/139839
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9082
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139839
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139839 | Water-insoluble reaction product of a polyamine and an oil-soluble high carbon polar modified polymer | Dec 15, 2009 | Issued |
Array
(
[id] => 8555212
[patent_doc_number] => 08329683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Treatment of neurofibromatosis with radicicol and its derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/631667
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 100055
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12631667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/631667 | Treatment of neurofibromatosis with radicicol and its derivatives | Dec 3, 2009 | Issued |
Array
(
[id] => 6359085
[patent_doc_number] => 20100087381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Method of Stimulating the Motility of the Gastrointestinal System Using Growth Hormone Secretagogues'
[patent_app_type] => utility
[patent_app_number] => 12/631490
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15962
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12631490
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/631490 | Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues | Dec 3, 2009 | Issued |
Array
(
[id] => 8772441
[patent_doc_number] => 08426397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => '3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/141447
[patent_app_country] => US
[patent_app_date] => 2009-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16346
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141447
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141447 | 3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives | Nov 25, 2009 | Issued |
Array
(
[id] => 7487419
[patent_doc_number] => 20110236379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/131298
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15877
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236379.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131298
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131298 | PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR | Nov 24, 2009 | Abandoned |
Array
(
[id] => 7651884
[patent_doc_number] => 20110301153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/129679
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7577
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301153.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129679
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129679 | METHODS OF TREATING CANCER | Nov 15, 2009 | Abandoned |
Array
(
[id] => 6591371
[patent_doc_number] => 20100130511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/619577
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 54450
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12619577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/619577 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Nov 15, 2009 | Issued |
Array
(
[id] => 7755527
[patent_doc_number] => 20120028249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/126234
[patent_app_country] => US
[patent_app_date] => 2009-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14060
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028249.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126234
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126234 | Anthraquinone based near IR emitting compounds and uses thereof | Oct 19, 2009 | Issued |
Array
(
[id] => 8305921
[patent_doc_number] => 08227456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/578660
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 24524
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578660 | Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives | Oct 13, 2009 | Issued |
Array
(
[id] => 7682256
[patent_doc_number] => 20100022552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'KMUP-1 CAPABLE OF TREATING HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 12/572519
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4480
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12572519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572519 | KMUP-1 CAPABLE OF TREATING HYPERTENSION | Oct 1, 2009 | Abandoned |
Array
(
[id] => 6016830
[patent_doc_number] => 20110224221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'HEMATOPOIETIC PROTECTION AGAINST IONIZING RADIATION USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/122017
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 22541
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224221.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122017 | HEMATOPOIETIC PROTECTION AGAINST IONIZING RADIATION USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS | Sep 30, 2009 | Abandoned |
Array
(
[id] => 7545458
[patent_doc_number] => 08053430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Treatment of renal cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/586849
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9334
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12586849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/586849 | Treatment of renal cell carcinoma | Sep 28, 2009 | Issued |
Array
(
[id] => 6257535
[patent_doc_number] => 20100029673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'THERAPEUTIC AGENTS COMPRISING AN ANTI-ANGIOGENIC AGENT IN COMBINATION WITH AN SRC-INHIBITOR AND THEIR THERAPEUTIC USE'
[patent_app_type] => utility
[patent_app_number] => 12/568643
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 40043
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12568643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568643 | THERAPEUTIC AGENTS COMPRISING AN ANTI-ANGIOGENIC AGENT IN COMBINATION WITH AN SRC-INHIBITOR AND THEIR THERAPEUTIC USE | Sep 27, 2009 | Abandoned |
Array
(
[id] => 6550018
[patent_doc_number] => 20100016587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Protein Kinase Targeted Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/566153
[patent_app_country] => US
[patent_app_date] => 2009-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8600
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016587.pdf
[firstpage_image] =>[orig_patent_app_number] => 12566153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/566153 | Protein kinase targeted therapeutics | Sep 23, 2009 | Issued |
Array
(
[id] => 7510202
[patent_doc_number] => 20110256241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/119488
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 36326
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256241.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119488
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119488 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | Sep 16, 2009 | Abandoned |
Array
(
[id] => 6495219
[patent_doc_number] => 20100093800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'APPARATUS, METHOD AND DRUG PRODUCTS FOR PROVIDING A CONSCIOUS PATIENT RELIEF FROM PAIN AND ANXIETY ASSOCIATED WITH MEDICAL OR SURGICAL PROCEDURES'
[patent_app_type] => utility
[patent_app_number] => 12/554033
[patent_app_country] => US
[patent_app_date] => 2009-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21989
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12554033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/554033 | APPARATUS, METHOD AND DRUG PRODUCTS FOR PROVIDING A CONSCIOUS PATIENT RELIEF FROM PAIN AND ANXIETY ASSOCIATED WITH MEDICAL OR SURGICAL PROCEDURES | Sep 3, 2009 | Abandoned |